1Q'24 vs. 1Q'23 Results Sales: € 247.4 M (+6.6% vs. +5.3% BS(e) and +4.0% consensus); EBITDA: € 52.5 M (+1.4% vs. -5.8% BS(e) and -7.3% consensus); EBIT: € 18.5 M (-8.9% vs. -23.6% BS(e) and -27.1% consensus); Net Profit: € 7.4 M (-3.9% vs. -54.5% BS(e) and -32.5% consensus);
Rdos. 1T'24 vs 1T'23: Ventas: 247,4 M euros (+6,6% vs +5,3% BS(e) y +4,0% consenso); EBITDA: 52,5 M euros (+1,4% vs -5,8% BS(e) y -7,3% consenso); EBIT: 18,5 M euros (-8,9% vs -23,6% BS(e) y -27,1% consenso); BDI: 7,4 M euros (-3,9% vs -54,5% BS(e) y -32,5% consenso).
COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: ALMIRALL, CELLNEX, GLOBAL DOMINION, GREENING, NATURGY. Incluido en el informe diario de hoy, y durante toda la campaña de resultados, incorporamos al final una presentación con los resultados destacados en positivo y negativo y previews de Rdos. 1T’24 que se publicarán en España y Europa en los próximos días. Semana de rebote en las bolsas Semana de rebote en las bolsas que se acercan a máximos del año después de que el Banco de Inglaterra allanase...
NEWS SUMMARY: ALMIRALL, CELLNEX, GLOBAL DOMINION, GREENING, NATURGY. At the end of today’s report, and during the entire results season, we will include a presentation with positive and negative results highlights and previews for the 1Q’24 results to be released over the coming days in Spain. Stock markets rallied last week Stock exchanges rallied last week, trading near annual highs after the Bank of England paved the way to initiate rate cuts next month and the governor Andrew Bailey stat...
BARCELONA, Spain--(BUSINESS WIRE)-- Almirall, S.A. (ALM) a global biopharmaceutical company based in Barcelona, today announced its financial results from the first quarter 2024. Almirall delivered strong sales growth in the first quarter of 2024 which continues to be driven by the dermatology business in Europe. Net Sales increased by 6.6% to a total of €247.4 MM, EBITDA was €52.5 MM (increase of 1.4% YoY) driven by higher sales growth, with a gross margin of 63.5%. Dermatology sales in Europe increased by 18.1% to a total of €113MM. Continued strong investments in supporting the Ebglyss laun...
>Q1 2024 slightly above expectations - IAG has just released its Q1 2024 results, slightly above estimates. Operating profit before exceptional items was reported at € 68m (€ 9m in Q1 2023), compared to the consensus (complied by company) estimate of € 48m, on sales of € 6,429m leading to a margin of 1.1% (0.2% in Q1 2024). This performance was mainly driven by passenger unit revenue for the year up 4.4% y-o-y (vs our estimate of +2.1%e) on capacity up 7% including ...
>Q1 2024 slightly above expectations - IAG has just released its Q1 2024 results, slightly above estimates. Operating profit before exceptional items was reported at € 68m (€ 9m in Q1 2023), compared to the consensus (complied by company) estimate of € 48m, on sales of € 6,429m leading to a margin of 1.1% (0.2% in Q1 2024). This performance was mainly driven by passenger unit revenue for the year up 4.4% y-o-y (vs our estimate of +2.1%e) on capacity up 7% including ...
NEWS SUMMARY: CAF, FERROVIAL, MELIÁ, SACYR. At the end of today’s report, and during the entire results season, we will include a presentation with positive and negative results highlights and previews for the 1Q’24 results to be released over the coming days in Spain. IBEX, bringing up the rear in Europe Most European indices saw an improvement over the course of the session, despite the increased tension in the Middle East and along with new rises in sovereign debt yields. The IBEX, des...
COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: CAF, FERROVIAL, MELIÁ, SACYR. Incluido en el informe diario de hoy, y durante toda la campaña de resultados, incorporamos al final una presentación con los resultados destacados en positivo y negativo y previews de Rdos. 1T’24 que se publicarán en España y Europa en los próximos días. El Ibex, a la cola en Europa Jornada de menos a más en la mayoría de índices europeos pese al incremento de la tensión en Oriente Próximo y acompañado de nuevos repu...
Unifiedpost is a niche SaaS player in the e-invoicing and procurement channel space. Regulatory headwinds mean this market is ripe for growth, which should benefit Unifiedpost. Due to some unsuccessful past M&A, the company is in a challenging financial position today. However, it has recently embarked on a divestment path, aiming to streamline the business and improve its fundamentals. We like the new direction, however prefer to take a wait-and-see approach. - ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.